On last trading day The Dow Chemical Company (NYSE:DOW) decreased -0.04% to close at $47.21. Its volatility for the week is 2.13% while volatility for the month is 1.73%. DOW’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was 68.70%. The Dow Chemical Company (NYSE:DOW) monthly performance is -4.61%. U.S. high-tech firm The Dow Chemical Company (NYSE:DOW)’s CEO on Tuesday advised China to further encourage entrepreneurship and innovation to climb up the global value chain. Andrew Liveris told Xinhua that China’s transition from low-end to medium and high manufacturing was the right strategy, but to this end, China needed to make more efforts.
Google Inc (NASDAQ:GOOG) has 0.19% insider ownership while its institutional ownership stands at 31.90%. In last trading activity company’s stock closed at $570.19. Google Inc. (NASDAQ:GOOG) has hired Ruth Porat as the company’s CFO to help cut some of the aggressive spending habits that the company has acquired over the last decade.
On last trading day Whiting Petroleum Corp. (NYSE:WLL) moved down -19.48% to close at $30.91. Its volatility for the week is 6.41% while volatility for the month is 6.15%. WLL’s sales growth for past 5 years was 26.90% and its EPS growth for past 5 years was 19.60%. Whiting Petroleum Corp. (NYSE:WLL) monthly performance is -18.49%. Whiting Petroleum Corporation (NYSE: WLL) announced that it has commenced a registered public offering of 35,000,000 shares of its common stock. Whiting expects to grant the underwriter a 30-day option to purchase up to an additional 5,250,000 shares of its common stock.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has 2.30% insider ownership while its institutional ownership stands at 66.80%. In last trading activity company’s stock closed at $203.11. Valeant Pharmaceuticals International Inc. (NYSE:VRX) has seemingly outlasted a rival bidder for a North Carolina-based specialty drug maker, Salix Pharmaceuticals Ltd., after upping its purchase offer last week by about $1 billion, to $15.8 billion.
On last trading day Sanofi SA (ADR) (NYSE:SNY) moved up 0.27% to close at $51.12. Its volatility for the week is 1.52% while volatility for the month is 1.14%. SNY’s sales growth for past 5 years was 1.80% and its EPS growth for past 5 years was -4.00%. Sanofi SA (ADR) (NYSE:SNY) monthly performance is 1.79%. On 20 March 2015, Amgen Inc. (NASDAQ:AMGN) and Sanofi SA (ADR) (NYSE:SNY) accompanied by Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) developed PCSK9 inhibitor as a category of new generation calculated potential results for the victims, that are already going through the treatment of statin. American College of Cardiology exhibited these consequences on medical journal England, declaring investors’ belief in this particular group of drugs.